Table of Contents Author Guidelines Submit a Manuscript
Volume 2010 (2010), Article ID 271504, 13 pages
Review Article

Lipid Metabolism and Cardiovascular Risk in HIV-1 Infection and HAART: Present and Future Problems

11st Division of Infectious Diseases, “Luigi Sacco” Hospital, Via GB Grassi, 74, 20157 Milan, Italy
2Clinical Pharmacology Unit, “Luigi Sacco” Hospital, 20157 Milan, Italy

Received 28 April 2010; Revised 15 August 2010; Accepted 7 September 2010

Academic Editor: Gloria L. Vega

Copyright © 2010 Sara Melzi et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Citations to this Article [9 citations]

The following is the list of published articles that have cited the current article.

  • E. Kelly Hester, “HIV Medications: An Update and Review of Metabolic Complications,” Nutrition in Clinical Practice, vol. 27, no. 1, pp. 51–64, 2012. View at Publisher · View at Google Scholar
  • Carlos J. Montoya, Edwin A. Higuita, Santiago Estrada, Francisco J. Gutierrez, Pedro Amariles, Newar A. Giraldo, Margarita M. Jimenez, Claudia P. Velasquez, Alba L. Leon, Maria T. Rugeles, and Fabian A. Jaimes, “Randomized clinical trial of lovastatin in HIV-infected, HAART naïve patients (NCT00721305),” Journal of Infection, vol. 65, no. 6, pp. 549–558, 2012. View at Publisher · View at Google Scholar
  • Yinzhong Shen, Zhenyan Wang, Li Liu, Renfang Zhang, Yufang Zheng, and Hongzhou Lu, “Prevalence of hyperglycemia among adults with newly diagnosed HIV/AIDS in China,” Bmc Infectious Diseases, vol. 13, 2013. View at Publisher · View at Google Scholar
  • Irini Sereti, and Jintanat Ananworanich, “Serious Non-AIDS events: Immunopathogenesis and interventional strategies,” Aids Research and Therapy, vol. 10, 2013. View at Publisher · View at Google Scholar
  • Himanshu Garg, Anjali Joshi, and Debabrata Mukherjee, “Cardiovascular complications of HIV infection and treatment,” Cardiovascular and Hematological Agents in Medicinal Chemistry, vol. 11, no. 1, pp. 58–66, 2013. View at Publisher · View at Google Scholar
  • Mariana Diaz-Zamudio, Damini Dey, Troy LaBounty, Michael Nelson, Zhaoyang Fan, Lidia S. Szczepaniak, Bill Pei-Chin Hsieh, Ronak Rajani, Daniel Berman, Debiao Li, Rohan Dharmakumar, W. David Hardy, and Antonio Hernandez Conte, “Increased pericardial fat accumulation is associated with increased intramyocardial lipid content and duration of highly active antiretroviral therapy,” Journal Of Cardiovascular Magnetic Resonance, vol. 17, 2015. View at Publisher · View at Google Scholar
  • Luis Furuya-Kanamori, Mark D. Kelly, and Samantha J. McKenzie, “Risk of cardiovascular disease in HIV-positive Queensland men receiving combined antiretroviral therapy,” Sexual Health, vol. 12, no. 4, pp. 348–352, 2015. View at Publisher · View at Google Scholar
  • L Jamieson, D Evans, At Brennan, F Moyo, D Spencer, K Mahomed, M Maskew, L Long, S Rosen, and Mp Fox, “Changes in elevated cholesterol in the era of tenofovir in South Africa: risk factors, clinical management and outcomes,” HIV Medicine, 2017. View at Publisher · View at Google Scholar
  • MacIej Banach, Agnieszka Jankowska-Zduñczyk, Piotr Hoffman, Piotr Jankowski, Jacek Joíwiak, Adam Windak, Jacek Rysz, Agnieszka Mastalerz-Migas, Barbara Cybulska, Tomasz Guzik, Artur Mamcarz, Marlena Broncel, and Tomasz Tomasik, “PoLA/CFPiP/PCS guidelines for the management of dyslipidaemias for family physicians 2016,” Archives of Medical Science, vol. 13, no. 1, pp. 1–45, 2017. View at Publisher · View at Google Scholar